Ritch N. Wood
Chief Executive Officer (CEO)
Ritch Wood was appointed Nu Skin’s chief executive officer in 2017. Previously, Wood served in various capacities at Nu Skin including chief financial officer, vice president of finance, vice president of new market development, director of finance of new market development and controller of the Pharmanex division. He also played a key role in opening many European countries for Nu Skin during an expatriate assignment from1995 to 1997. Prior to his assignment in Europe, he served as the assistant director of international tax.
Wood worked for the international accounting firm of Grant Thornton prior to joining Nu Skin in 1993. He earned a Bachelor of Science and Master of Accountancy, taxation emphasis, from Brigham Young University and in 2010 was named a CFO of the Year by Utah Business magazine.
Ryan Napierski currently serves as President of Global Sales and Operations. Prior to his current appointment, he has been serving as the President of Nu Skin’s North Asia region and President of Nu Skin Japan.
Napierski has also served as President of Nu Skin Japan and as Vice President of Business Development for the North Asia region. He has fulfilled multiple positions for Nu Skin since joining the company in 1995, including a dual role overseeing corporate strategy for the Japan market and acting as Vice President of Global Business Development for Corporate Distributor Success, acting as General Manager for the United Kingdom, Vice President of European Business Development and Key Account Manager for United States executives.
Napierski has a bachelor’s degree in business, a master’s degree in business administration from Duke University and a master’s degree in international business from Goethe Universitat in Germany.
Joseph Y. Chang, Ph.D.
Chief Scientific Officer and Executive Vice President, Product Development
Joseph Y. Chang, Ph.D., was appointed Chief Scientific Officer and Executive Vice President of Product Development in February 2006. Dr. Chang enjoys a comprehensive knowledge of both the pharmaceutical and dietary supplement industries and serves as a member of the Executive Committee for Nu Skin Enterprises. He formerly served as president and chief scientific officer of Pharmanex. Prior to Pharmanex, Dr. Chang served as both president and chief scientific officer at Binary Therapeutics, Inc. from 1994 to 1997 and at OsteoArthritis Sciences, Inc. from 1991 to 1994. He has also held various executive research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and cancer treatment. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research during his nearly 20 years in the health care industry. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.
D. Matthew Dorny
Vice President, General Counsel and Secretary
D. Matthew Dorny was appointed General Counsel and Chief Legal Officer in March 2006. Prior to this appointment, he served as Vice President and General Counsel, and Assistant General Counsel for Nu Skin Enterprises. Prior to joining Nu Skin Enterprises, Mr. Dorny was a securities and business attorney in private practice. Mr. Dorny received a B.A., M.B.A. and J.D. degree from the University of Utah.